Why the SILK Laser (ASX:SLA) share price is pushing higher

Here's how this growing company is performing in FY 2021…

| More on:
A happy shopper with lots of bright shopping bags, indicating a positive surge for ASX retail share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The SILK Laser Australia Ltd (ASX: SLA) share price is on the move on Monday morning.

In early trade, the laser, skin care, and cosmetic injections company's shares are up 3% to $3.92.

This means the SILK share price is now up 13.5% from its December IPO price of $3.45.

Why is the SILK share price rising today?

Investors have been buying the company's shares this morning after it announced the achievement of a key milestone.

According to the release, SILK has now reached a total of 60 clinics nationwide after opening two new clinics in Woden, ACT and Charlestown, NSW.

The release advises that the new clinic openings are in line with SILK's organic network growth strategy of rolling out additional clinics in markets where it is currently under-penetrated, including Canberra and Newcastle.

SILK has now opened ten new clinics in FY 2021, with two more clinics expected to open by the end of the month. This will exceed SILK's organic growth goal of opening six to ten new clinics per annum as the company progresses to its medium-term network plan of approximately 150 clinics.

The new Woden and Charlestown clinics operate under the joint venture ownership model, with leading cosmetic injectable nurses as SILK's joint venture partners in these clinics.

Both joint venture partners have a strong existing client base in their respective markets. As a result, the new clinics are expected to ramp up sales quickly and generate positive cash flow and EBITDA in their first year of operation.

Management commentary

SILK's Managing Director and Co-Founder, Martin Perelman, commented: "We are very excited to launch our newest injector-led clinics in Woden and Charlestown. The joint venture ownership model offers the injector nurses an attractive entry into business ownership while allowing us to attract key talent to SILK and deliver strong clinic performance from day-one."

"Our first clinic in Canberra opened in March this year and, pleasingly, it has performed in line with expectations. We see great potential in the ACT market, and we're excited to expand our presence there to two locations following the opening of our Woden clinic."

"The Charlestown clinic in Newcastle is off to a flying start, recording SILK's highest opening day of sales on record. We are fortunate to have two experienced nurse injectors with strong existing client bases onboard to lead our newest clinics, and I am confident that they will be successful in their respective markets," he concluded.

Trading update

SILK also revealed that it remains on track to achieve its upgraded guidance in FY 2021.

Network cash sales is expected in the range of $82 million to $86 million, with pro forma EBITDA forecast to be in the range of $15 million to $16 million.

James Mickleboro does not own any shares mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Dimerix, Newmont, Regal Partners, and Titomic shares are storming higher

These shares are having a good finish to the week. Let's see why.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Fortescue, Lynas, PEXA, and Regis Healthcare shares are charging higher

These shares are having a strong session on Thursday. But why?

Read more »

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Share Gainers

Why Capricorn Metals, Insignia, Perseus Mining, and Qoria shares are storming higher

These shares are having a strong session on Tuesday. But why?

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Amaero, AMP, Block, and South32 shares are racing higher today

These shares are starting the week on a positive note. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another momentous session for ASX shares this Friday.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why BHP, Catalyst Metals, Mesoblast, and Pilbara Minerals shares are shooting higher

These shares are ending the week with a bang. But why?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »